Search Tag: AOP Orphan
2014 25 Nov
AOP Orphan, a European pioneer in the field of rare diseases, is expanding its sales area for the preparation of Thromboreductin® to include the Russian market. The drug is an innovative treatment option for patients afflicted by Essential Thrombocythemia (ET), a rare but serious bone marrow disease. The drug is currently available in core...Read more